Prostate cancer and health-related quality of life: A review of the literature

Psycho-Oncology

Volumn 11, Issue 4, 2002, Pages 307-326

  Eton, David T ^a,c   Lepore, Stephen J ^b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b CITY UNIVERSITY OF NEW YORK   (United States)

^c Research and Education   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIANDROGEN; ANTINEOPLASTIC AGENT; GONADORELIN DERIVATIVE; HORMONE;

ADVANCED CANCER; AGE; CANCER CHEMOTHERAPY; CANCER HORMONE THERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CLINICAL TRIAL; CRYOSURGERY; DISEASE DURATION; DRUG EFFECT; ENERGY; EVIDENCE BASED MEDICINE; HEALTH; HUMAN; INTESTINE FUNCTION; KIDNEY FUNCTION; MALE; MEDICAL LITERATURE; PHYSICAL PERFORMANCE; PROSTATE CANCER; PROSTATECTOMY; QUALITY OF LIFE; REVIEW; SEXUAL FUNCTION; SOCIAL LIFE; TRANSURETHRAL RESECTION;

AGED; FECAL INCONTINENCE; HEALTH BEHAVIOR; HEALTH STATUS; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROSTATIC NEOPLASMS; QUALITY OF LIFE; SEXUAL DYSFUNCTION, PHYSIOLOGICAL; URINATION DISORDERS;

EID: 0036653964     PISSN: 10579249     EISSN: None     Source Type: Journal    
DOI: 10.1002/pon.572     Document Type: Review

References (60)

1. Health-related quality of life among patients with metastatic prostate cancer
2. Assessment of patient preferences among men with prostate cancer
3. How is quality of life in prostate cancer patients influenced by modern treatment? The Wallenberg Symposium
4. Complications after treatment with external-beam irradiation in early-stage prostate cancer patients: A prospective multiinstitutional outcomes study
5. A comparison of perspectives on prostate cancer: Analysis of utility assessments of patients and physicians
6. Cryosurgery in prostatic cancer: Survival
7. Quality of life in patients with prostatic cancer: Results from a Swedish population study
8. Quality of life and psychosocial status in stage D prostate cancer. Zoladex Prostate Cancer Study Group
9. Nerve-sparing radical prostatectomy: Evaluation of results after 250 patients
10. Nerve-sparing radical prostatectomy: Extraprostatic tumor extension and preservation of erectile function
11. Measuring quality of life in palliative care
12. Quality of life in cancer: Definition, purpose, and method of measurement
13. Single-agent therapy with bicalutamide: A comparison with medical or surgical castration in the treatment of advanced prostate carcinoma
14. Results of conservative management of clinically localized prostate cancer
15. Changes in quality of life following treatment for early prostate cancer
16. Baseline quality of life of patients with advanced prostate cancer. European Organization for Research and Treatment of Cancer (EORTC), Genito-Urinary Cancer Cooperative Group (GUT-CCG)
17. The quality of life of patients with newly diagnosed M1 prostate cancer: Experience with EORTC clinical trial 30853
18. Radical prostatectomy with preservation of sexual function: Pathological findings in the first 100 cases
19. A decision analysis of alternative treatment strategies for clinically localized prostate cancer
20. Influence of urological morbidity on quality of life in patients with prostate cancer
21. Outcomes of external-beam radiation therapy for prostate cancer: A study of Medicare beneficiaries in three Surveillance, Epidemiology, and End Results areas
22. Results of radical prostatectomy in men with clinically localized prostate cancer: Multi-institutional pooled analysis
23. Radiotherapy or surgery for prostate cancer? Ten and fifteen-year results of external beam therapy
24. Comparison of prostate cancer patients with and without pain
25. Factors associated with waning sexual function among elderly men and prostate cancer patients
26. Waning sexual function - The most important disease-specific distress for patients with prostate cancer
27. Quality of life in prostate cancer patients
28. A comparison of the quality of life of patients with metastatic prostate cancer who received or did not receive hormonal therapy
29. Casodex (bicalutamide) 150-mg monotherapy compared with castration in patients with previously untreated nonmetastatic prostate cancer: Results from two multicenter randomized trials at a median follow-up of 4 years
30. Health-related quality of life and sequelae in patients treated with brachytherapy and external beam irradiation for localized prostate cancer
31. The general health policy model: An integrated approach
32. Psychoeducational support group enhances quality of life after prostate cancer
33. Quality of life: Radical prostatectomy versus radiation therapy for prostate cancer
34. Quality-of-life outcomes in men treated for localized prostate cancer
35. Recovery of health related quality of life in the year after radical prostatectomy: Early experience
36. Quality-of-life outcomes in long-term survivors of advanced prostate cancer
37. Changes in health-related quality of life in the first year after treatment for prostate cancer: Results from CaPSURE
38. Population-based study of long-term survival in patients with clinically localised prostate cancer
39. Prostate cancer clinical guidelines panel summary report on the management of clinically localized prostate cancer
40. Quality of life in advanced prostate cancer: Results of a randomized therapeutic trial
41. Neuromuscular fatigue in prostate cancer patients undergoing radiation therapy
42. Use of palliative end points to evaluate the effects of mitoxantrone and low-dose prednisone in patients with hormonally resistant prostate cancer
43. Quality of life and sexuality following radical prostatectomy in patients with prostate cancer who use or do not use erectile aids
44. Prostate cancer practice patterns and quality of life: The Prostate Cancer Outcomes Study
45. Health outcomes after prostatectomy or radiotherapy for prostate cancer: Results from the Prostate Cancer Outcomes Study
46. Rapid screening for psychologic distress in men with prostate carcinoma
47. Quality of life in adult survivors of lung, colon and prostate cancer
48. Treatment related sequelae following external beam radiation for prostate cancer: A review with an update in patients with stages T1 and T2 tumor
49. Quality of life and treatment outcomes: Prostate carcinoma patients' perspectives after prostatectomy or radiation therapy
50. Urinary and sexual function after radical prostatectomy for clinically localized prostate cancer: The prostate cancer outcomes study
51. Responsiveness to change in health-related quality of life in a randomized clinical trial: A comparison of the Prostate Cancer Specific Quality of Life Instrument (PROSQOLI) with analogous scales from the EORTC QLQ-C30 and a trial specific module. European Organization for Research and Treatment of Cancer
52. Treatment of metastatic prostatic cancer with low-dose prednisone: Evaluation of pain and quality of life as pragmatic indices of response
53. Quality of life in patients undergoing salvage procedures for locally recurrent prostate cancer
54. A randomised comparison of 'Casodex' (bicalutamide) 150 mg monotherapy versus castration in the treatment of metastatic and locally advanced prostate cancer
55. Quality of life in patients with prostatic carcinoma: A review and results of a study in N + disease. Prostate-specific antigen as predictor of quality of life
56. A structured literature review of treatment for localized prostate cancer
57. Quality of life of patients with prostate cancer treated with surgery or radiation therapy
58. The hospital anxiety and depression scale